- Home
- NEXT vs RCKT Comparison
NEXT vs RCKT Comparison
Compare NEXT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEXT
- RCKT
- Stock Information
- Founded
- NEXT 2010
- RCKT 1999
- Country
- NEXT United States
- RCKT United States
- Employees
- NEXT N/A
- RCKT N/A
- Industry
- NEXT Oil & Gas Production
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- NEXT Energy
- RCKT Health Care
- Exchange
- NEXT Nasdaq
- RCKT Nasdaq
- Market Cap
- NEXT 1.4B
- RCKT 1.9B
- IPO Year
- NEXT N/A
- RCKT N/A
- Fundamental
- Price
- NEXT $5.93
- RCKT $17.13
- Analyst Decision
- NEXT Hold
- RCKT Strong Buy
- Analyst Count
- NEXT 1
- RCKT 9
- Target Price
- NEXT $9.00
- RCKT $53.22
- AVG Volume (30 Days)
- NEXT 1.1M
- RCKT 731.3K
- Earning Date
- NEXT 11-11-2024
- RCKT 11-04-2024
- Dividend Yield
- NEXT N/A
- RCKT N/A
- EPS Growth
- NEXT N/A
- RCKT N/A
- EPS
- NEXT N/A
- RCKT N/A
- Revenue
- NEXT N/A
- RCKT N/A
- Revenue This Year
- NEXT N/A
- RCKT N/A
- Revenue Next Year
- NEXT N/A
- RCKT $300.20
- P/E Ratio
- NEXT N/A
- RCKT N/A
- Revenue Growth
- NEXT N/A
- RCKT N/A
- 52 Week Low
- NEXT $4.01
- RCKT $15.98
- 52 Week High
- NEXT $8.52
- RCKT $32.53
- Technical
- Relative Strength Index (RSI)
- NEXT 63.68
- RCKT 46.41
- Support Level
- NEXT $5.35
- RCKT $17.05
- Resistance Level
- NEXT $5.98
- RCKT $17.75
- Average True Range (ATR)
- NEXT 0.27
- RCKT 0.72
- MACD
- NEXT 0.04
- RCKT 0.06
- Stochastic Oscillator
- NEXT 79.22
- RCKT 40.23
About NEXT NextDecade Corporation
NextDecade Corp is a energy company predominantly engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The company provides a number of services depending on the individual needs of the customer. These include the supply and trade of LNG volumes, the creation of new natural gas infrastructure including pipeline and natural gas liquefaction facilities, treatment and processing of natural gas into LNG, as well as technical engineering and design services related to the development and execution of natural gas infrastructure, transporting, shipping and storage of LNG.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.